Santé log11h
HÔPITAL : La pénurie d’infirmières, c’est des décès en plus
Accèdez sans limite aux 15 000 actualités du site et recevez gratuitement chaque semaine, la Newsletter Santé log avec les actus Santé à ne pas manquer !
Santé log23h
Conception Nurseries Launches TrueClones™ X
Conception Nurseries, the world’s largest cannabis micropropagation company that provides performance-tested tissue culture ...
Santé log23h
Georgiamune Announces First Participant Dosed in First-In-Class Phase 1 Healthy Volunteers Trial of GIM-407
In the ongoing phase 1 study, GIM-407 will be administered orally to healthy volunteers to further characterize the safety, tolerability, and pharmacokinetics. Data collected from this study will help ...
Santé log23h
Standard BioTools Achieves New Record of the Most Protein Measurements on the Most Sample Types with Expansion of the SomaScan® 11K Platform
Standard BioTools Inc. (Nasdaq:LAB), today announced that the SomaScan ® 11K Platform now includes protein measurements on a broader range of sample types, including cerebrospinal fluid (CSF), aqueous ...
Santé log23h
CytoDyn Announces Preliminary Findings in Study with SMC Laboratories
VANCOUVER, Washington, Sept. 24, 2024 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential ...
Santé log23h
Spectral AI Achieves 25% Patient Enrollment at Emergency Departments for U.S. Burn Pivotal Study and Adds Two New Clinical Trial Sites
One of the largest domestic burn studies ever conducted, the U.S. Burn Pivotal Study is designed to validate the AI-driven algorithm used by the Company’s DeepView ® System for burn indication ...
Santé log23h
Tersa Earth and Silica-X Sign MoU to Revolutionize Mining and Waste Management with AI-Powered Biotech and Zero-Waste Solutions
Enhance computational models that predict and improve the efficiency of chemical reactions in biotech-enabled mining operations. Reduce costs and testing time by offering predictive input/output ...
Santé log23h
First Patient Enrolled in Phase I Program in STK11 Mutant Non-Small Cell Lung Cancer at Moffitt Cancer Center
(OTCQB: PBLA), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today announced the first patient enrolled in a Phase I dose ...
Santé log23h
TRxADE Health, Inc. Announces Name Change to Scienture Holdings, Inc. and Ticker Symbol Change to “SCNX”
TRxADE Health, Inc. today announced that it changed its name and ticker symbol to “Scienture Holdings, Inc.” and “SCNX”, respectively, and that the business will continue as a Nasdaq-listed company.
Santé log23h
Cassava Sciences Announces Completion of an Interim Safety Review of Oral Simufilam On-going Phase 3 Trials
An Independent Data and Safety Monitoring Board (DSMB) Recently Evaluated the Interim Patient Safety Database for Oral Simufilam in On-going Phase 3 Trials. The DSMB Recommended Both Phase 3 Trials ...
Santé log23h
Altamira Therapeutics Provides Business Update and First Half 2024 Financial Results
Company to host conference call today at 8.30 a.m. ET Continued progress within core activities in RNA delivery, supported by move into new R&D facilities Publications by independent research groups ...
Santé log23h
Surrozen Earns $10 Million Milestone Payment in Retinal Diseases Collaboration
Surrozen is pioneering targeted therapeutics that selectively activate the Wnt pathway for tissue repair and regeneration. The milestone achievement triggers a $10 million payment to Surrozen as part ...